Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases

doi:10.4254/wjh.v12.i11.1046

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6125)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

446

WORD

151

HTML

3234

Figures (1-3)

316

Tables (1-4)

245

Sum=4392

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

516

Download

1217

Sum=1733

Nov 27, 2020 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Nov 27, 2020; 12(11): 1046-1054
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1046

Table 4 Treatment methods of hepatocellular carcinoma patients

Therapy	No of treated patients
	Group
	≤ 2 cm, n = 394	> 2 cm, n = 539
Hepatectomy	45	110
RFA	223	107
TACE	56	136
TACE + RFA	6	32
TAI	2	10
Chemotherapy	9	21
BSC	10	60
Others	13	63

BSC: Best supportive care; RFA: Radiofrequency ablation; TACE: Transcatheter arterial chemoembolization; TAI: Transcatheter arterial infusion.

Citation: Tarao K, Nozaki A, Komatsu H, Komatsu T, Taguri M, Tanaka K, Chuma M, Numata K, Maeda S. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases. World J Hepatol 2020; 12(11): 1046-1054
URL: https://www.wjgnet.com/1948-5182/full/v12/i11/1046.htm
DOI: https://dx.doi.org/10.4254/wjh.v12.i11.1046